Cardiocentro Ticino Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01666132
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Cardiocentro Ticino | Istituto Cardiocentro Ticino

Active Ingredients

Drugs in Phase 4 Trials (1)

pramipexole (mirapex) (1 trial)

Drugs in Phase 2 Trials (1)

autologous bone marrow derived mesenchymal cells (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Psychomotor Agitation (Phase 4)

Restless Legs Syndrome (Phase 4)

Syndrome (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2